The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
Open accessAbstract
SUMMARY The development of precision medicine approaches for diffuse large B cell lymphoma (DLBCL) is confounded by its pronounced genetic, phenotypic, and clinical heterogeneity. Recent multiplatform genomic studies revealed the existence of genetic subtypes of DLBCL using clustering methodologies. Here, we describe an algorithm that determines the probability that a patient’s lymphoma belongs to one of seven genetic subtypes based on its genetic features. This classification reveals genetic similarities between these DLBCL subtypes and various indolent and extranodal lymphoma types, suggesting a shared pathogenesis. These genetic subtypes also have distinct gene expression profiles, immune microenvironments, and outcomes following immunochemotherapy. Functional analysis of genetic subtype models highlights distinct vulnerabilities to targeted therapy, supporting the use of this classification in precision medicine trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationInduction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801445 · Cited by 2,241
Self-citationIκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Self-citationChronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Self-citationOncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Self-citationGenomic Instability in Mice Lacking Histone H2AX
Celeste, A., Petersen, S., Romanienko, P. J., Fernandez-Capetillo, O., Chen, H. T., Sedelnikova, O. A., Reina-San-Martin, B., Coppola, V., Meffre, E., Difilippantonio, M. J., et al. (2002) · Science · doi:10.1126/science.1069398 · Cited by 1,385
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Matsushita, H., Vesely, M. D., Koboldt, D. C., Rickert, C. G., Uppaluri, R., Magrini, V. J., Arthur, C. D., White, J. M., Chen, Y.-S., Shea, L. K., et al. (2012) · Nature · doi:10.1038/nature10755 · Cited by 1,288
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Mutations driving CLL and their evolution in progression and relapse
Landau, D. A., Tausch, E., Taylor-Weiner, A. N., Stewart, C., Reiter, J. G., Bahlo, J., Kluth, S., Bozic, I., Lawrence, M., Böttcher, S., et al. (2015) · Nature · doi:10.1038/nature15395 · Cited by 1,068
Davis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
Self-citationQuesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Lenz, G., Wright, G. W., Emre, N. C. T., Kohlhammer, H., Dave, S. S., Davis, R. E., Carty, S., Lam, L. T., Shaffer, A. L., Xiao, W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804295105 · Cited by 995
Self-citationBurkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 924
Self-citationMolecular Diagnosis of Burkitt's Lymphoma
Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E.-J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055759 · Cited by 897
Self-citationNon-coding recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2015) · Nature · doi:10.1038/nature14666 · Cited by 829
Okosun, J., Bödör, C., Wang, J., Araf, S., Yang, C.-Y., Pan, C., Boller, S., Cittaro, D., Bozek, M., Iqbal, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.2856 · Cited by 734
Self-citationHLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading
Denzin, L. K., & Cresswell, P. (1995) · Cell · doi:10.1016/0092-8674(95)90061-6 · Cited by 686
Multiple layers of B cell memory with different effector functions
Dogan, I., Bertocci, B., Vilmont, V., Delbos, F., Mégret, J., Storck, S., Reynaud, C.-A., & Weill, J.-C. (2009) · Nature Immunology · doi:10.1038/ni.1814 · Cited by 635
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Steidl, C., Shah, S. P., Woolcock, B. W., Rui, L., Kawahara, M., Farinha, P., Johnson, N. A., Zhao, Y., Telenius, A., Neriah, S. B., et al. (2011) · Nature · doi:10.1038/nature09754 · Cited by 615
Self-citationMYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
The genetic landscape of mutations in Burkitt lymphoma
Love, C., Sun, Z., Jima, D., Li, G., Zhang, J., Miles, R., Richards, K. L., Dunphy, C. H., Choi, W. W. L., Srivastava, G., et al. (2012) · Nature Genetics · doi:10.1038/ng.2468 · Cited by 597
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Chapuy, B., Roemer, M. G. M., Stewart, C., Tan, Y., Abo, R. P., Zhang, L., Dunford, A. J., Meredith, D. M., Thorner, A. R., Jordanova, E. S., et al. (2016) · Blood · doi:10.1182/blood-2015-10-673236 · Cited by 585
Genetics of Follicular Lymphoma Transformation
Pasqualucci, L., Khiabanian, H., Fangazio, M., Vasishtha, M., Messina, M., Holmes, A. B., Ouillette, P., Trifonov, V., Rossi, D., Tabbò, F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.027 · Cited by 573
Sciammas, R., Shaffer, A. L., Schatz, J. H., Zhao, H., Staudt, L. M., & Singh, H. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.009 · Cited by 571
Self-citationSaito, T., Chiba, S., Ichikawa, M., Kunisato, A., Asai, T., Shimizu, K., Yamaguchi, T., Yamamoto, G., Seo, S., Kumano, K., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00111-0 · Cited by 561
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2016) · Nature · doi:10.1038/nature18910 · Cited by 546
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
Self-citationGlobal mapping of c-Myc binding sites and target gene networks in human B cells
Zeller, K. I., Zhao, X., Lee, C. W. H., Chiu, K. P., Yao, F., Yustein, J. T., Ooi, H. S., Orlov, Y. L., Shahab, A., Yong, H. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604129103 · Cited by 516
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Beà, S., Valdés-Mas, R., Navarro, A., Salaverria, I., Martín-Garcia, D., Jares, P., Giné, E., Pinyol, M., Royo, C., Nadeu, F., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314608110 · Cited by 513
Self-citationInhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Lionakis, M. S., Dunleavy, K., Roschewski, M., Widemann, B. C., Butman, J. A., Schmitz, R., Yang, Y., Cole, D. E., Melani, C., Higham, C. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.012 · Cited by 508
Self-citationThe proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
Dominguez-Sola, D., Victora, G. D., Ying, C. Y., Phan, R. T., Saito, M., Nussenzweig, M. C., & Dalla-Favera, R. (2012) · Nature Immunology · doi:10.1038/ni.2428 · Cited by 490
Scherer, F., Kurtz, D. M., Newman, A. M., Stehr, H., Craig, A. F. M., Esfahani, M. S., Lovejoy, A. F., Chabon, J. J., Klass, D. M., Liu, C. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8545 · Cited by 484
Crescenzo, R., Abate, F., Lasorsa, E., Tabbo’, F., Gaudiano, M., Chiesa, N., Di Giacomo, F., Spaccarotella, E., Barbarossa, L., Ercole, E., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.006 · Cited by 443
the ICGC MMML-Seq Project (2012) · Nature Genetics · doi:10.1038/ng.2469 · Cited by 440
Challa-Malladi, M., Lieu, Y. K., Califano, O., Holmes, A. B., Bhagat, G., Murty, V. V., Dominguez-Sola, D., Pasqualucci, L., & Dalla-Favera, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.006 · Cited by 439
Ennishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
Self-citationIbrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Grommes, C., Pastore, A., Palaskas, N., Tang, S. S., Campos, C., Schartz, D., Codega, P., Nichol, D., Clark, O., Hsieh, W.-Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0613 · Cited by 409
Scott, D. W., Mottok, A., Ennishi, D., Wright, G. W., Farinha, P., Ben-Neriah, S., Kridel, R., Barry, G. S., Hother, C., Abrisqueta, P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2383 · Cited by 405
Self-citationShechter, R., London, A., & Schwartz, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3391 · Cited by 403
TFH cells progressively differentiate to regulate the germinal center response
Weinstein, J. S., Herman, E. I., Lainez, B., Licona-Limón, P., Esplugues, E., Flavell, R., & Craft, J. (2016) · Nature Immunology · doi:10.1038/ni.3554 · Cited by 399
A multiprotein supercomplex controlling oncogenic signalling in lymphoma
Phelan, J. D., Young, R. M., Webster, D. E., Roulland, S., Wright, G. W., Kasbekar, M., Shaffer, A. L., Ceribelli, M., Wang, J. Q., Schmitz, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0290-0 · Cited by 398
Self-citationRossi, D., Trifonov, V., Fangazio, M., Bruscaggin, A., Rasi, S., Spina, V., Monti, S., Vaisitti, T., Arruga, F., Famà, R., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120904 · Cited by 379
Self-citationMathews Griner, L. A., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 377
Self-citationGreen, M. R., Kihira, S., Liu, C. L., Nair, R. V., Salari, R., Gentles, A. J., Irish, J., Stehr, H., Vicente-Dueñas, C., Romero-Camarero, I., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501199112 · Cited by 355
Lam, L. T., Wright, G., Davis, R. E., Lenz, G., Farinha, P., Dang, L., Chan, J. W., Rosenwald, A., Gascoyne, R. D., & Staudt, L. M. (2008) · Blood · doi:10.1182/blood-2007-09-111948 · Cited by 353
Self-citationAntigen receptor repertoire profiling from RNA-seq data
Bolotin, D. A., Poslavsky, S., Davydov, A. N., Frenkel, F. E., Fanchi, L., Zolotareva, O. I., Hemmers, S., Putintseva, E. V., Obraztsova, A. S., Shugay, M., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3979 · Cited by 333
Green, M. R., Gentles, A. J., Nair, R. V., Irish, J. M., Kihira, S., Liu, C. L., Kela, I., Hopmans, E. S., Myklebust, J. H., Ji, H., et al. (2013) · Blood · doi:10.1182/blood-2012-09-457283 · Cited by 321
Ennishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., Bashashati, A., Saberi, S., Boyle, M., Meissner, B., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1090 · Cited by 318
Suppression of antigen presentation by IL-10
Mittal, S. K., & Roche, P. A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.009 · Cited by 314
Sha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., Kennedy, H., Thompson, J. S., Uddin, R., Worrillow, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01314 · Cited by 300
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
Muppidi, J. R., Schmitz, R., Green, J. A., Xiao, W., Larsen, A. B., Braun, S. E., An, J., Xu, Y., Rosenwald, A., Ott, G., et al. (2014) · Nature · doi:10.1038/nature13765 · Cited by 295
Self-citationKiel, M. J., Velusamy, T., Betz, B. L., Zhao, L., Weigelin, H. G., Chiang, M. Y., Huebner-Chan, D. R., Bailey, N. G., Yang, D. T., Bhagat, G., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120910 · Cited by 284
Genetics of diffuse large B-cell lymphoma
Pasqualucci, L., & Dalla-Favera, R. (2018) · Blood · doi:10.1182/blood-2017-11-764332 · Cited by 282
Pfeifer, M., Grau, M., Lenze, D., Wenzel, S.-S., Wolf, A., Wollert-Wulf, B., Dietze, K., Nogai, H., Storek, B., Madle, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305656110 · Cited by 270
Suan, D., Kräutler, N. J., Maag, J. L. V., Butt, D., Bourne, K., Hermes, J. R., Avery, D. T., Young, C., Statham, A., Elliott, M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.022 · Cited by 242
Zhang, J., Jima, D., Moffitt, A. B., Liu, Q., Czader, M., Hsi, E. D., Fedoriw, Y., Dunphy, C. H., Richards, K. L., Gill, J. I., et al. (2014) · Blood · doi:10.1182/blood-2013-07-517177 · Cited by 236
A library of gene expression signatures to illuminate normal and pathological lymphoid biology
Shaffer, A. L., Wright, G., Yang, L., Powell, J., Ngo, V., Lamy, L., Lam, L. T., Davis, R. E., & Staudt, L. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00373.x · Cited by 228
Self-citationRecurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
Nakamura, T., Tateishi, K., Niwa, T., Matsushita, Y., Tamura, K., Kinoshita, M., Tanaka, K., Fukushima, S., Takami, H., Arita, H., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12259 · Cited by 227
Braggio, E., Van Wier, S., Ojha, J., McPhail, E., Asmann, Y. W., Egan, J., da Silva, J. A., Schiff, D., Lopes, M. B., Decker, P. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2116 · Cited by 222
Heise, N., De Silva, N. S., Silva, K., Carette, A., Simonetti, G., Pasparakis, M., & Klein, U. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132613 · Cited by 220
Monti, S., Chapuy, B., Takeyama, K., Rodig, S. J., Hao, Y., Yeda, K. T., Inguilizian, H., Mermel, C., Currie, T., Dogan, A., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.014 · Cited by 207
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Okosun, J., Wolfson, R. L., Wang, J., Araf, S., Wilkins, L., Castellano, B. M., Escudero-Ibarz, L., Al Seraihi, A. F., Richter, J., Bernhart, S. H., et al. (2016) · Nature Genetics · doi:10.1038/ng.3473 · Cited by 205
Self-citationAgarwal, R., Chan, Y.-C., Tam, C. S., Hunter, T., Vassiliadis, D., Teh, C. E., Thijssen, R., Yeh, P., Wong, S. Q., Ftouni, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0243-z · Cited by 203
Self-citationSurvival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Young, R. M., Wu, T., Schmitz, R., Dawood, M., Xiao, W., Phelan, J. D., Xu, W., Menard, L., Meffre, E., Chan, W.-C. C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514944112 · Cited by 191
Self-citationGenomic characterization of primary central nervous system lymphoma
Fukumura, K., Kawazu, M., Kojima, S., Ueno, T., Sai, E., Soda, M., Ueda, H., Yasuda, T., Yamaguchi, H., Lee, J., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1536-2 · Cited by 188
Mutational analysis of primary central nervous system lymphoma
Bruno, A., Boisselier, B., Labreche, K., Marie, Y., Polivka, M., Jouvet, A., Adam, C., Figarella-Branger, D., Miquel, C., Eimer, S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2080 · Cited by 185
Ceribelli, M., Kelly, P. N., Shaffer, A. L., Wright, G. W., Xiao, W., Yang, Y., Mathews Griner, L. A., Guha, R., Shinn, P., Keller, J. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411701111 · Cited by 185
Self-citationRecurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma
Krysiak, K., Gomez, F., White, B. S., Matlock, M., Miller, C. A., Trani, L., Fronick, C. C., Fulton, R. S., Kreisel, F., Cashen, A. F., et al. (2017) · Blood · doi:10.1182/blood-2016-07-729954 · Cited by 183
Germinal center‐derived lymphomas: The darkest side of humoral immunity
Mlynarczyk, C., Fontán, L., & Melnick, A. (2019) · Immunological Reviews · doi:10.1111/imr.12755 · Cited by 179
Dominguez, P. M., Ghamlouch, H., Rosikiewicz, W., Kumar, P., Béguelin, W., Fontán, L., Rivas, M. A., Pawlikowska, P., Armand, M., Mouly, E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0657 · Cited by 178
The genetics of nodal marginal zone lymphoma
Spina, V., Khiabanian, H., Messina, M., Monti, S., Cascione, L., Bruscaggin, A., Spaccarotella, E., Holmes, A. B., Arcaini, L., Lucioni, M., et al. (2016) · Blood · doi:10.1182/blood-2016-02-696757 · Cited by 177
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Landau, D. A., Sun, C., Rosebrock, D., Herman, S. E. M., Fein, J., Sivina, M., Underbayev, C., Liu, D., Hoellenriegel, J., Ravichandran, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02329-y · Cited by 176
Clipson, A., Wang, M., de Leval, L., Ashton-Key, M., Wotherspoon, A., Vassiliou, G., Bolli, N., Grove, C., Moody, S., Escudero-Ibarz, L., et al. (2015) · Leukemia · doi:10.1038/leu.2014.330 · Cited by 176
Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment
Young, R. M., Phelan, J. D., Wilson, W. H., & Staudt, L. M. (2019) · Immunological Reviews · doi:10.1111/imr.12792 · Cited by 172
Self-citationHuman germinal center transcriptional programs are de-synchronized in B cell lymphoma
Milpied, P., Cervera-Marzal, I., Mollichella, M.-L., Tesson, B. M., Brisou, G., Traverse‐Glehen, A., Salles, G. A., Spinelli, L., & Nadel, B. (2018) · Nature Immunology · doi:10.1038/s41590-018-0181-4 · Cited by 169
Vater, I., Montesinos-Rongen, M., Schlesner, M., Haake, A., Purschke, F., Sprute, R., Mettenmeyer, N., Nazzal, I., Nagel, I., Gutwein, J., et al. (2015) · Leukemia · doi:10.1038/leu.2014.264 · Cited by 166
Lü, D., Liu, L., Ji, X., Gao, Y., Chen, X., Liu, Y., Liu, Y., Zhao, X., Li, Y., Li, Y., et al. (2015) · Nature Immunology · doi:10.1038/ni.3278 · Cited by 163
Ljungström, V., Cortese, D., Young, E., Pandzic, T., Mansouri, L., Plevová, K., Ntoufa, S., Baliakas, P., Clifford, R. M., Sutton, L., et al. (2015) · Blood · doi:10.1182/blood-2015-10-674572 · Cited by 162
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
Parry, M., Rose-Zerilli, M. J. J., Ljungström, V., Gibson, J., Wang, J., Walewska, R. J., Parker, H., Parker, A. E., Davis, Z. A., Gardiner, A. C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2759 · Cited by 159
Self-citationKelly, P. N., Romero, D. L., Yang, Y., Shaffer, A. L., Chaudhary, D., Robinson, S., Miao, W., Rui, L., Westlin, W. F., Kapeller, R., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151074 · Cited by 158
Self-citationWu, C., de Miranda, N. F. C. C., Chen, L., Wasik, A. M., Mansouri, L., Jurczak, W. J., Gałązka, K., Długosz‐Danecka, M., Machaczka, M., Zhang, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9500 · Cited by 141
Self-citationGoy, A. H., Ramchandren, R., Ghosh, N., Munoz, J. L., Morgan, D., Dang, N. H., Knapp, M. H., Delioukina, M. L., Kingsley, E. C., Ping, J., et al. (2019) · Blood · doi:10.1182/blood.2018891598 · Cited by 137
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody
Singh, M., Jackson, K., Wang, J. J., Schofield, P., Field, M. A., Koppstein, D., Peters, T. J., Burnett, D. L., Rizzetto, S., Névoltris, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.029 · Cited by 133
Self-citationBouska, A. C., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J. M., Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., et al. (2016) · Leukemia · doi:10.1038/leu.2016.175 · Cited by 125
Self-citationMintz, M. A., Felce, J. H., Chou, M. Y., Mayya, V., Xu, Y., Shui, J., An, J., Li, Z., Marson, A., Okada, T., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.022 · Cited by 123
Kraan, W., van Keimpema, M., Horlings, H. M., Schilder-Tol, E. J. M., Oud, M. E. C. M., Noorduyn, L. A., Kluin, P. M., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2013) · Leukemia · doi:10.1038/leu.2013.348 · Cited by 120
Mareschal, S., Pham‐Ledard, A., Viailly, P., Dubois, S., Bertrand, P., Maingonnat, C., Fontanilles, M., Bohers, É., Ruminy, P., Tournier, I., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.010 · Cited by 117
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Havránek, O., Xu, J., Köhrer, S., Wang, Z., Becker, L. M., Comer, J. M., Henderson, J. M., Ma, W., Ma, M. C. J., Westin, J. R., et al. (2017) · Blood · doi:10.1182/blood-2016-10-747303 · Cited by 111
Cristofano, A. D. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.11.006 · Cited by 109
Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2
Hodson, D. J., Shaffer, A. L., Xiao, W., Wright, G. W., Schmitz, R., Phelan, J. D., Yang, Y., Webster, D. E., Rui, L., Kohlhammer, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600557113 · Cited by 108
Self-citationMartínez, N., Almaráz, C., Vaque, J. P., Varela, I., Derdak, S. V., Beltrán, S., Mollejo, M., Campos‐Martín, Y., Águeda, L., Rinaldi, A., et al. (2013) · Leukemia · doi:10.1038/leu.2013.365 · Cited by 107
Beà, S., Colomo, L., López‐Guillermo, A., Salaverría, I., Puig, X., Pinyol, M., Rives, S., Montserrat, E., & Campo, E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.025 · Cited by 99
Hartmann, S., Schuhmacher, B., Rausch, T., Fuller, L., Döring, C., Weniger, M. A., Lollies, A., Weiser, C., Thurner, L., Rengstl, B., et al. (2015) · Leukemia · doi:10.1038/leu.2015.328 · Cited by 99
Fontanilles, M., Marguet, F., Bohers, É., Viailly, P., Dubois, S., Bertrand, P., Camus, V., Mareschal, S., Ruminy, P., Maingonnat, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18325 · Cited by 98
Linossi, E. M., & Nicholson, S. E. (2015) · Immunological Reviews · doi:10.1111/imr.12305 · Cited by 97
Gain-of-function IKBKB mutation causes human combined immune deficiency
Cardinez, C., Miraghazadeh, B., Tanita, K., da Silva, E., Hoshino, A., Okada, S., Chand, R., Asano, T., Tsumura, M., Yoshida, K., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180639 · Cited by 97
Parry, M., Rose-Zerilli, M. J. J., Gibson, J., Ennis, S., Walewska, R. J., Forster, J., Parker, H., Davis, Z. A., Gardiner, A. C., Collins, A. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083244 · Cited by 91
S-Geranylgeranyl-l-glutathione is a ligand for human B cell-confinement receptor P2RY8
Lu, E., Wolfreys, F. D., Muppidi, J. R., Xu, Y., & Cyster, J. G. (2019) · Nature · doi:10.1038/s41586-019-1003-z · Cited by 85
Keep‐ING balance: Tumor suppression by epigenetic regulation
Tallen, G. R. N., & Riabowol, K. T. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.011 · Cited by 83
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Nogai, H., Wenzel, S.-S., Hailfinger, S., Grau, M., Kaergel, E., Seitz, V., Wollert‐Wulf, B., Pfeifer, M., Wolf, A., Frick, M., et al. (2013) · Blood · doi:10.1182/blood-2013-06-508028 · Cited by 82
Bouska, A. C., Bi, C., Lone, W., Zhang, W., Kedwaii, A., Heavican, T. B., Lachel, C. M., Yu, J., Ferro, R., Eldorghamy, N., et al. (2017) · Blood · doi:10.1182/blood-2017-02-767335 · Cited by 80
Self-citationEnnishi, D., Healy, S., Bashashati, A., Saberi, S., Hother, C. E., Mottok, A., Chan, F. C., Chong, L. C., Abraham, L., Kridel, R., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0757-z · Cited by 80
Self-citationCD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential
Yonese, I., Takase, H., Yoshimori, M., Onozawa, E., Tsuzura, A., Miki, T., Mochizuki, M., Miura, O., & Arai, A. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13191 · Cited by 79
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
Rui, L., Drennan, A. C., Ceribelli, M., Zhu, F., Wright, G. W., Huang, D. W., Xiao, W., Li, Y., Grindle, K. M., Lü, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610970113 · Cited by 76
Self-citationHellmuth, J. C., Louissaint, A., Szczepanowski, M., Haebe, S., Pastore, A., Alig, S., Staiger, A. M., Hartmann, S., Kridel, R., Ducar, M. D., et al. (2018) · Blood · doi:10.1182/blood-2018-03-837252 · Cited by 72
Zhou, X. A., Louissaint, A., Wenzel, A. T., Yang, J., Martínez‐Escala, M. E., Moy, A. P., Morgan, E. A., Paxton, C. N., Hong, B., Andersen, E., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.04.038 · Cited by 70
Amin, N. A., Seymour, E. K., Saiya-Cork, K., Parkin, B. L., Shedden, K., & Malek, S. N. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3103 · Cited by 68
High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations
Pillonel, V., Juškevičius, D., Ng, C. K. Y., Bodmer, A., Zettl, A., Jucker, D., Dirnhofer, S., & Tzankov, A. (2018) · Leukemia · doi:10.1038/s41375-018-0082-4 · Cited by 67
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Suehara, Y., Sakata‐Yanagimoto, M., Hattori, K., Nanmoku, T., Itoh, T., Kaji, D., Yamamoto, G., Abe, Y., Narita, K., Takeuchi, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.178830 · Cited by 67
Schuhmacher, B., Bein, J., Rausch, T., Beneš, V., Tousseyn, T., Vornanen, M., Ponzoni, M., Thurner, L., Gascoyne, R. D., Steidl, C., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.203224 · Cited by 65
Zhou, Y., Liu, W., Xu, Z., Zhu, H., Xiao, D., Su, W., Zeng, R., Feng, Y., Duan, Y., Zhou, J., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.012 · Cited by 61
Johansson, P., Klein‐Hitpaß, L., Grabellus, F., Arnold, G., Klapper, W., Pförtner, R., Dührsen, U., Eckstein, A. K., Dürig, J., & Küppers, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11548 · Cited by 60
マウスおよびヒトはい中心におけるCCR6は記憶B細胞前駆体,光帯を明らかにする位置と主要な低抗原親和性【Powered by NICT】
Dan, S., Nike, J. K., Jesper, L. V. M., Danyal, B., Bourne, K., Jana, R., Tullman‐Ercek, D., Young, C., Aaron, S., Michael, E., et al. (2017) · Immunity · Cited by 57
Hyeon, J., Lee, B., Shin, S., Yoo, H. Y., Kim, S. J., Kim, W. S., Park, W., & Ko, Y. H. (2018) · Modern Pathology · doi:10.1038/s41379-018-0064-0 · Cited by 43
Hickmann, A., Frick, M., Hadaschik, D., Battke, F., Bittl, M., Ganslandt, O., Biskup, S., & Döcker, D. (2019) · BMC Cancer · doi:10.1186/s12885-019-5394-x · Cited by 43
Ducharme, O., Beylot-Barry, M., Pham‐Ledard, A., Bohers, É., Viailly, P., Bandres, T., Faur, N., Frison, É., Vergier, B., Jardin, F., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.008 · Cited by 41
Floßbach, L., Antoneag, E., Buck, M., Siebert, R., Mattfeldt, T., Mӧller, P., & Barth, T. F. E. (2010) · International Journal of Cancer · doi:10.1002/ijc.25663 · Cited by 40
Shin, S., Kim, Y. J., Lee, D., Cho, D., Ko, Y. H., Cho, J., Park, W., Park, D., Kim, S. J., & Kim, W. S. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1573998 · Cited by 36
Zamò, A., Pischimarov, J., Schlesner, M., Rosenstiel, P. C., Bomben, R., Horn, H., Grieb, T., Nedeva, T., López, C., Haake, A., et al. (2017) · Leukemia · doi:10.1038/leu.2017.270 · Cited by 35
Mutational profile of primary breast diffuse large B-cell lymphoma
Franco, F., González‐Rincón, J., Lavernia, J., García, J. F., Martín, P., Bellas, C., Piris, M. A., Pedrosa, L., Miramón, J., Gómez‐Codina, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21986 · Cited by 31
High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
Tsukamoto, T., Nakano, M., Sato, R., Adachi, H., Kiyota, M., Kawata, E., Uoshima, N., Yasukawa, S., Chinen, Y., Mizutani, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14150-0 · Cited by 21
Hattori, K., Sakata‐Yanagimoto, M., Kusakabe, M., Nanmoku, T., Suehara, Y., Matsuoka, R., Noguchi, M., Yokoyama, Y., Kato, T., Kurita, N., et al. (2018) · Cancer Science · doi:10.1111/cas.13848 · Cited by 21
Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines
Webster, D. E., Roulland, S., & Phelan, J. D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9151-8_16 · Cited by 17
Self-citation
Cited by
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. D. O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., et al. (2022) · Leukemia · doi:10.1038/s41375-022-01620-2 · Cited by 4,004
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Self-citationSehn, L. H., & Salles, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2027612 · Cited by 1,175
Vercellino, L., Di Blasi, R., Kanoun, S., Tessoulin, B., Rossi, C., D'Aveni-Piney, M., Obéric, L., Bodet-Milin, C., Bories, P., Olivier, P., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003001 · Cited by 410
The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma
Steen, C. B., Luca, B. A., Esfahani, M. S., Azizi, A., Sworder, B. J., Nabet, B. Y., Kurtz, D. M., Liu, C. L., Khameneh, F., Advani, R. H., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.011 · Cited by 332
Metadata
- Authors
- Wright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., Jiang, A., Bagaev, A., Plotnikova, O., Kotlov, N., Johnson, C. A., Wilson, W. H., Scott, D. W., & Staudt, L. M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 37
- Issue
- 4
- Pages
- 551-568.e14
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W3016044607
- Cited by
- 1,169
- References
- 128
- FWCI
- 86.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.